Animal experiments suggest that opiate peptides might play a role in 
extrapyramidal function. This hypothesis was tested by administering the opiate 
antagonist, naltrexone, in doses sufficient to antagonize exogenous opiates, to 
patients with parkinsonism and Huntington's disease. No improvement in the 
clinical features of either disorder was noted.